» Articles » PMID: 21209807

Peripheral Neuropathy and VIth Nerve Palsy Related to Randall Disease Successfully Treated by High-Dose Melphalan, Autologous Blood Stem Cell Transplantation, and VIth Nerve Decompression Surgery

Overview
Journal Case Rep Med
Publisher Wiley
Specialty General Medicine
Date 2011 Jan 7
PMID 21209807
Authors
Affiliations
Soon will be listed here.
Abstract

Randall disease is an unusual cause of extraocular motor nerve (VI) palsy. A 35-year-old woman was hospitalized for sicca syndrome. The physical examination showed general weakness, weight loss, diplopia related to a left VIth nerve palsy, hypertrophy of the submandibular salivary glands, and peripheral neuropathy. The biological screening revealed renal insufficiency, serum monoclonal kappa light chain immunoglobulin, urinary monoclonal kappa light chain immunoglobulin, albuminuria, and Bence-Jones proteinuria. Bone marrow biopsy revealed medullar plasma cell infiltration. Immunofixation associated with electron microscopy analysis of the salivary glands showed deposits of kappa light chains. Randall disease was diagnosed. The patient received high-dose melphalan followed by autostem cell transplantation which led to rapid remission. Indeed, at the 2-month followup assessment, the submandibular salivary gland hypertrophy and renal insufficiency had disappeared, and the peripheral neuropathy, proteinuria, and serum monoclonal light chain had decreased significantly. The persistent diplopia was treated with nerve decompression surgery of the left extraocular motor nerve. Cranial nerve complications of Randall disease deserve to be recognized.

References
1.
Zakrzewski P, Weis E, White V, Rootman J . Intracellular extraocular muscle light- and heavy-chain deposition disease contributing to compressive optic neuropathy in a patient with preexisting Graves' orbitopathy. Ophthalmologica. 2009; 224(1):59-62. DOI: 10.1159/000235727. View

2.
Grassi M, Clerici F, Perin C, Borella M, Gendarini A, Quattrini A . Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient. Ital J Neurol Sci. 2000; 19(4):229-33. DOI: 10.1007/BF02427609. View

3.
Ronco P, Alyanakian M, Mougenot B, Aucouturier P . Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001; 12(7):1558-1565. DOI: 10.1681/ASN.V1271558. View

4.
Randall R, Williamson Jr W, MULLINAX F, Tung M, Still W . Manifestations of systemic light chain deposition. Am J Med. 1976; 60(2):293-9. DOI: 10.1016/0002-9343(76)90440-x. View

5.
Katoh N, Matsuda M, Yoshida T, Yazaki M, Morita H, Sakashita K . Primary AL amyloid polyneuropathy successfully treated with high-dose melphalan followed by autologous stem cell transplantation. Muscle Nerve. 2009; 41(1):138-43. DOI: 10.1002/mus.21483. View